Silencing SMAD4 inhibits inflammation and ferroptosis in asthma by blocking the IL-17A signaling pathway
Silencing SMAD4 prevents inflammation and ferroptosis in asthma by inhibiting the IL-17 pathway, which provides a novel potential approach for asthma therapy.
Authors
- Kaiyuan Luo
- Xingyu Rao (ORCID: https://orcid.org/0000-0003-0892-6281)
- Hong Luo (ORCID: https://orcid.org/0000-0002-9501-651X)
- Chaohua Hu (ORCID: https://orcid.org/0000-0001-5996-5390)
Institutions
- Gannan Medical University (CN)
- First Affiliated Hospital of Gannan Medical University (CN)
Publication Details
- Journal
- Respiratory Research
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1186/s12931-024-03052-1
- Citations
- 8
- Primary Topic
- TGF-β signaling in diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.87